These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 501087)

  • 1. Generation of biologic activity from the purified alpha-chain of C5.
    Phan SH; Ward PA
    J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
    Wetsel RA; Kolb WP
    J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of the fourth, second and fifth components of mouse complement.
    Fukuoka Y; Seino J; Okuda T; Tachibana T
    Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
    Minta JO; Man DP
    J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural features and biologic properties of fragments obtained by limited proteolysis of C3.
    Conroy MC; Ozols J; Lepow IH
    J Immunol; 1976 Jun; 116(6):1682-7. PubMed ID: 774990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited proteolysis of C5b-6: functional stability of the degraded complex.
    Podack ER; Müller-Eberhard HJ
    J Immunol; 1980 Jan; 124(1):332-6. PubMed ID: 6444229
    [No Abstract]   [Full Text] [Related]  

  • 10. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
    Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
    J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.
    Nilsson UR; Mandle RJ; McConnell-Mapes JA
    J Immunol; 1975 Feb; 114(2 pt 2):815-22. PubMed ID: 1112981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.
    Muhlfelder TW; Niemetz J; Kreutzer D; Beebe D; Ward PA; Rosenfeld SI
    J Clin Invest; 1979 Jan; 63(1):147-50. PubMed ID: 762243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Shingu M; Nobunaga M
    Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.
    Wetsel RA; Kolb WP
    J Immunol; 1982 May; 128(5):2209-16. PubMed ID: 7061860
    [No Abstract]   [Full Text] [Related]  

  • 16. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of the fifth component of the bovine complement system.
    Aston WP; Mhatre A; Macrae J
    Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
    J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization and utilization of the fifth component (C5) of porcine complement.
    Vĕtvicka V; Zídková J; Fornůsek L; Ríhová B
    Folia Biol (Praha); 1986; 32(3):195-208. PubMed ID: 2943607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of reduction on the structural, biologic, and immunologic properties of the third component of human complement.
    Zemel ES; Cartwright-Harwick CM; Nilsson UR
    J Immunol; 1980 Sep; 125(3):1099-103. PubMed ID: 7410831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.